Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed1
Other2

Role Distribution

Other Roles3

Activity Timeline

Clinical Trials (3)

NCT04092647Phase 2Unknown
Ashwagandha for Cognitive Dysfunction
Chemo Fog
StudydirectorStart date: 2023-01-01
NCT03319810Phase 2Completed
Effect of IVIG on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer Disease
Mild Cognitive Impairment
StudydirectorStart date: 2018-01-04
NCT04027478Not ApplicableUnknown
Can Fasting Decrease the Side Effects of Chemotherapy?
Chemotherapeutic ToxicityChemotherapy EffectFasting
Studydirector

Research Network

Collaboration Network

4 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Stacy D'Andre, MD

Sutter Health

Moderately Similar
1 trials

Shared therapeutic areas:

Chemotherapeutic ToxicityChemotherapy EffectFasting

Worked with same sponsors:

Sutter Health
Collaborated on 1 trial
Similarity Score34%

Shawn Kile, MD

Sutter Health

Related
2 trials

Shared therapeutic areas:

Mild Cognitive Impairment

Worked with same sponsors:

Sutter Health
Collaborated on 1 trial
Similarity Score14%

Deepti Behl, MD

Sutter Health

Related
1 trials

Shared therapeutic areas:

Chemotherapy-Related Cognitive Impairment

Worked with same sponsors:

Sutter Health
Collaborated on 1 trial
Similarity Score14%

Ming Chen, PhD

Zhejiang Cancer Hospital

Related
5 trials

Shared therapeutic areas:

Chemotherapeutic ToxicityChemotherapy Effect
Similarity Score12%

Nicolai Goettel, MD

University Hospital, Basel, Switzerland

Related
8 trials

Shared therapeutic areas:

Mild Cognitive Impairment
Similarity Score6%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Chemotherapy Effect
Similarity Score6%

Gerhard Garhöfer, MD

Department of Clinical Pharmacology, Medical University of Vienna

Related
10 trials

Shared therapeutic areas:

Mild Cognitive Impairment
Similarity Score6%

Mariana Figueiro, PhD

Icahn School of Medicine at Mount Sinai

Related
10 trials

Shared therapeutic areas:

Mild Cognitive Impairment
Similarity Score6%

Jill Crandall, MD

Albert Einstein College of Medicine

Related
4 trials

Shared therapeutic areas:

Fasting
Similarity Score6%

David Huang, MD, PhD

Oregon Health and Science University

Related
8 trials

Shared therapeutic areas:

Mild Cognitive Impairment
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04092647Phase 2StudyDirector

Ashwagandha for Cognitive Dysfunction

Chemo Fog
Unknown
NCT03319810Phase 2StudyDirector

Effect of IVIG on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer Disease

Mild Cognitive Impairment
Completed
NCT04027478Not ApplicableStudyDirector

Can Fasting Decrease the Side Effects of Chemotherapy?

Chemotherapeutic ToxicityChemotherapy EffectFasting
Unknown

All 3 trials loaded